PRESS RELEASES

PRESS RELEASES

May 5, 2015
Company Continues to See Record Revenue Growth, Gross Profit Increases and Improved Gross Margins First Quarter Highlights: Total revenue increased 6.6% to $9.5 million from $8.9 million reported in first quarter of 2014 Gross profit increased 9.6% to $6.0 million compared to $5.5 million reported
May 4, 2015
BELGRADE, Mont. , May 4, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has established a record date for its 2015 annual meeting of stockholders. Bacterin stockholders of record at the close of business
April 23, 2015
BELGRADE, Mont. , April 23, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period ended March 31, 2015 , on May 5, 2015 at the close of
April 9, 2015
First Quarter Total Revenue Expected to be in the Range of $9.4 Million to $9.5 Million, an Increase of Approximately 5-7% Over the Same Period Last Year BELGRADE, Mont. , April 9, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of
April 8, 2015
BELGRADE, Mont. , April 8, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material, today announced that it received written notice from the staff at NYSE Regulation, Inc.
April 6, 2015
BELGRADE, Mont. , April 6, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, is pleased to announce that the United States Patent and Trademark Office has issued US Patent No.
March 17, 2015
Fourth Quarter Highlights: Total revenue increased to $9.1 million from $8.3 million in Q4 2013, an increase of 10.0% over the prior year Gross profit increased to $5.8 million compared to $4.1 million in Q4 2013, an increase of 41.2% over the prior year Gross margins improved to 63.5%, an increase
March 16, 2015
BELGRADE, Mont. , March 16, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced that it has extended its contract with Novation for an additional year. The extension will allow Bacterin to continue to